Zusammenfassung
Unter dem Druck des zunehmenden PSA-Screenings ist es zu einer fortwährenden Optimierung in der histopathologischen Karzinomdiagnostik gekommen. Bei Einhaltung entsprechender Qualitätsstandards hinsichtlich Biopsieentnahme als auch der Gewebeaufarbeitung ist selbst die Identifizierung kleinster Karzinomherde sicher möglich. Standardisierungsbemühungen in der Gleason-Graduierung sollen zusätzlich helfen, Aussagen hinsichtlich der Tumorbiologie weiter zu präzisieren. Die subtile Diagnose von Karzinomvorstufen bzw. karzinomassoziierter Läsion erlaubt darüber hinaus, zunehmend genauere Vorhersagen zum bestehenden Karzinomrisiko zu treffen. Schwächen bestehen unverändert in der sicheren Erkennung klinisch insignifikanter Karzinome und der Gefahr einer Übertherapie. Hier ist weitere Forschungsaktivität erforderlich.
Abstract
Driven by the pressure of increasing use of PSA screening, cancer diagnosis based on histopathology has been constantly improved. When appropriate quality standards for obtaining a biopsy specimen and for tissue preparation are upheld, even the smallest tumour foci can be identified with certainty. Efforts to standardize the Gleason grading should also help to render assessments of tumour biology more precise. In addition, subtle diagnosis of precancerous or cancer-associated lesions will permit more exact prognoses of existing cancer risk to be made. There are still weak points: reliable recognition of clinically insignificant carcinomas and the danger of overtreatment. Further research activity on this topic is needed.
Literatur
Haas GP, Delongchamps NB, Jones RF et al (2007) Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence. J Natl Cancer Inst 99:1484–1489
van der Kwast TH, Lopes C, Santonja C et al (2003) Guidelines for processing and reporting of prostatic needle biopsies. J Clin Pathol 56:336–340
Jiang Z, Wu CL, Woda BA et al (2002) P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol 26:1169–1174
McNeal JE, Bostwick DG (1986) Intraductal dysplasia: a premalignant lesion of the prostate. Hum Pathol 17:64–71
Bostwick DG, Brawer MK (1987) Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 59:788–794
Bostwick DG, Grignon DJ, Hammond ME et al (2000) Prognostic factors in prostate cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:995–1000
Epstein JI, Herawi M (2006) Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol 175:820–834
Gokden N, Roehl KA, Catalona WJ et al (2005) High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population. Urology 65:538–542
Netto GJ, Epstein JI (2006) Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma. Am J Surg Pathol 30:1184–1188
Wu CL, Yang XJ, Tretiakova M et al (2004) Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Hum Pathol 35:1008–1013
Kronz JD, Shaikh AA, Epstein JI (2001) High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy. Hum Pathol 32:389–395
Alsikafi NF, Brendler CB, Gerber GS et al (2001) High-grade prostatic intraepithelial neoplasia with adjacent atypia is associated with a higher incidence of cancer on subsequent needle biopsy than high-grade prostatic intraepithelial neoplasia alone. Urology 57:296–300
de Vries SH, Postma R, Raaijmakers R et al (2007) Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer section Rotterdam. Eur Urol 51:366–374
D’Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974
Bangma CH, Roemeling S, Schröder FH (2007) Overdiagnosis and overtreatment of early detected prostate cancer. World J Urol 25:3–9
Epstein JI, Chan DW, Sokoll LJ et al (1998) Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J Urol 160:2407–2411
Jeldres C, Suardi N, Walz J et al (2008) Validation of the contemporary epstein criteria for insignificant prostate cancer in European men. Eur Urol 54:1306–1313
Gleason DF (1966) Classification of prostatic carcinomas. Cancer Chemother Rep 50:125–128
Djavan B (1998): Gleason scores from prostate biopsies obtained with 18-gauge biopsy needles poorly predict gleason scores of radical prostatectomy specimens. Curr Opin Urol 8:441
Koksal IT, Ozcan F, Kadioglu TC et al (2000) Discrepancy between Gleason scores of biopsy and radical prostatectomy specimens. Eur Urol 37:670–674
Pinthus JH, Witkos M, Fleshner NE et al (2006) Prostate cancers scored as Gleason 6 on prostate biopsy are frequently Gleason 7 tumors at radical prostatectomy: implication on outcome. J Urol 176:979–984
Humphrey PA (2004) Gleason grading and prognostic factors in carcinoma of the prostate. Mod Pathol 17:292–306
Pan CC, Potter SR, Partin AW et al (2000) The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system. Am J Surg Pathol 24:563–569
Epstein JI, Allsbrook WC Jr, Amin MB et al (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 29:1228–1242
Helpap B, Egevad L (2006) The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens. Virchows Arch 449:622–627
Lin KK (2008) Prostate cancer at one end of a needle biopsy core is associated with advanced pathology stage. Mod Pathol 21:166A
Egan AJ, Bostwick DG (1997) Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis. Am J Surg Pathol 21:1496–1500
Beard CJ, Chen MH, Cote K et al (2004) Perineural invasion is associated with increased relapse after external beam radiotherapy for men with low-risk prostate cancer and may be a marker for occult, high-grade cancer. Int J Radiat Oncol Biol Phys 58:19–24
Quinn DI, Henshall SM, Brenner PC et al. (2003) Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion. Cancer 97:1884–1893
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Köllermann, J., Sauter, G. Histologische Diagnostik an der Prostatastanzbiopsie. Urologe 48, 305–314 (2009). https://doi.org/10.1007/s00120-009-1966-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-009-1966-8
Schlüsselwörter
- Prostatakarzinom
- Prostatastanzbiopsiediagnostik
- Tumorspezifisches Aggressionspotenzial
- Patientenindividualsierte Differenzialtherapie
- ASAP